The U.S. government awarded a firm fixed-price purchase order valued at $10,692 to Qiagen, LLC for a QIA CUBE Service Agreement. The contract, awarded on July 14, 2015, with an ultimate completion date of August 2, 2016, was issued by a civilian federal agency's Southeast Area office and is to be performed in Athens, Georgia. This purchase order represents a child contract under Qiagen N.V., a multinational biotechnology company headquartered in the Netherlands. The award was made without a set-aside designation, reflecting open market competition. Qiagen, LLC, based in Germantown, Maryland, is a specialized provider of molecular diagnostics equipment, reagents, and bioinformatics solutions.
The QIAcube is an automated DNA/RNA extraction instrument widely utilized across federal agencies for sample preparation in molecular diagnostics and research applications. This service agreement likely encompasses maintenance, technical support, or consumables associated with the QIAcube platform. Qiagen maintains an extensive portfolio of federal contracts across multiple agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Federal Bureau of Investigation, with several significant indefinite delivery vehicles in place. The company's federal offerings support critical initiatives in biomedical research, public health, healthcare operations, and law enforcement investigations requiring advanced molecular testing capabilities.
Generated 1/13/26, 10:19 AM